4.6 Review

A review of phototherapy protocols for psoriasis treatment

Journal

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 64, Issue 5, Pages 936-949

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2009.12.054

Keywords

excimer; light; monochromatic; narrowband; NB-UVB; psoralen; psoriasis; PUVA; targeted; ultraviolet; UVA; UVB

Categories

Funding

  1. Galderma Laboratories, L.P.
  2. National Biological Corporation
  3. Connetics
  4. Roche
  5. Amgen
  6. Biogen
  7. Genentech
  8. Abbott
  9. Centacor
  10. Neostrata
  11. Galderma
  12. Warner-Chilcott

Ask authors/readers for more resources

Phototherapy is a mainstay in the treatment of psoriasis and is available as psoralen plus UVA (PUVA), broadband UVB (BB-UVB), and narrowband UVB (NB-UVB). Phototherapy can be administered in the hospital, outpatient clinic, or in the patient's home. The purpose of this review is to provide some practical guidance to general dermatologists and residents on the specifics of using phototherapy, which, despite its decreasing use, remains one of our most safe and effective treatment strategies for psoriasis care. We conducted a literature review of home phototherapy, BB-UVB, NB-UVB, and PUVA phototherapy using PubMed, MD Consult, and reference lists. A variety of protocols for BB-UVB, NB-UVB, and PUVA have been used in clinical trials. NB-UVB is more effective than BB-UVB and safer than PUVA. Typical regimens for NB-UVB involve dosing 3 times per week for at least 3 months. Treatment must be independently developed to suit each participant's needs. Ultraviolet light is an effective, relatively safe modality that is a valuable tool in the treatment of psoriasis. NB-UVB phototherapy is considered the first-line treatment for extensive plaque type psoriasis. (J Am Acad Dermatol 2011;64:936-49.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available